DAVIS TRENT D 4
4 · INVO Bioscience, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
DAVIS TRENT D
Director
Transactions
- Award
Common Stock
2022-01-15+8,865→ 22,438 total - Award
Stock Option
2022-01-15+10,771→ 10,771 totalExercise: $3.61Exp: 2032-01-14→ Common Stock (10,771 underlying)
Footnotes (1)
- [F1]The stock option vest in monthly increments over a period of twelve months from the date of grant.